Literature DB >> 1417187

Muscle protein breakdown during endotoxemia in rats and after treatment with interleukin-1 receptor antagonist (IL-1ra).

O Zamir1, P O Hasselgren, W O'Brien, R C Thompson, J E Fischer.   

Abstract

The purpose of this study was to examine the effect of endotoxemia on muscle protein degradation and to test the hypothesis that muscle proteolysis during endotoxemia is regulated by interleukin-1 (IL-1). Both total and myofibrillar protein breakdown rates in incubated extensor digitorum longus muscles were increased after the subcutaneous injection of 0.1 or 1.0 mg/kg endotoxin in rats. The endotoxin-induced increase in muscle protein breakdown was blunted by IL-1 receptor antagonist, administered intraperitoneally at a total dose of 45 or 105 mg/kg. Results suggest that endotoxemia in rats gives rise to sepsislike changes in muscle protein breakdown. Increased muscle protein breakdown during endotoxemia may be regulated, at least in part, by IL-1.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1417187      PMCID: PMC1242630          DOI: 10.1097/00000658-199209000-00018

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  32 in total

1.  In vitro preparations of the diaphragm and other skeletal muscles.

Authors:  A L Goldberg; S B Martel; M J Kushmerick
Journal:  Methods Enzymol       Date:  1975       Impact factor: 1.600

2.  The effect of interleukin-1 alpha and the glucocorticoid receptor blocker RU 38486 on total and myofibrillar protein breakdown in skeletal muscle.

Authors:  O Zamir; P O Hasselgren; D von Allmen; J E Fischer
Journal:  J Surg Res       Date:  1991-06       Impact factor: 2.192

3.  Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma.

Authors:  G H Clowes; B C George; C A Villee; C A Saravis
Journal:  N Engl J Med       Date:  1983-03-10       Impact factor: 91.245

4.  Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist.

Authors:  S P Eisenberg; R J Evans; W P Arend; E Verderber; M T Brewer; C H Hannum; R C Thompson
Journal:  Nature       Date:  1990-01-25       Impact factor: 49.962

5.  Interleukin-1 receptor antagonist reduces mortality from endotoxin shock.

Authors:  K Ohlsson; P Björk; M Bergenfeldt; R Hageman; R C Thompson
Journal:  Nature       Date:  1990-12-06       Impact factor: 49.962

6.  A specific receptor antagonist for interleukin 1 prevents Escherichia coli-induced shock in rabbits.

Authors:  G Wakabayashi; J A Gelfand; J F Burke; R C Thompson; C A Dinarello
Journal:  FASEB J       Date:  1991-03-01       Impact factor: 5.191

7.  Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction.

Authors:  D J Dripps; B J Brandhuber; R C Thompson; S P Eisenberg
Journal:  J Biol Chem       Date:  1991-06-05       Impact factor: 5.157

Review 8.  Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro.

Authors:  C A Dinarello; R C Thompson
Journal:  Immunol Today       Date:  1991-11

9.  Interleukin-1 receptor antagonist binds to the type II interleukin-1 receptor on B cells and neutrophils.

Authors:  D J Dripps; E Verderber; R K Ng; R C Thompson; S P Eisenberg
Journal:  J Biol Chem       Date:  1991-10-25       Impact factor: 5.157

10.  A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice.

Authors:  H R Alexander; G M Doherty; C M Buresh; D J Venzon; J A Norton
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307

View more
  11 in total

Review 1.  Cytokines in exertion-induced skeletal muscle injury.

Authors:  J G Cannon; B A St Pierre
Journal:  Mol Cell Biochem       Date:  1998-02       Impact factor: 3.396

Review 2.  Thermoregulation as a disease tolerance defense strategy.

Authors:  Alexandria M Palaferri Schieber; Janelle S Ayres
Journal:  Pathog Dis       Date:  2016-11-03       Impact factor: 3.166

Review 3.  The ubiquitin-proteasome pathway: review of a novel intracellular mechanism of muscle protein breakdown during sepsis and other catabolic conditions.

Authors:  P O Hasselgren; J E Fischer
Journal:  Ann Surg       Date:  1997-03       Impact factor: 12.969

Review 4.  Respiratory muscle dysfunction in sepsis.

Authors:  S N Hussain
Journal:  Mol Cell Biochem       Date:  1998-02       Impact factor: 3.396

5.  Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor {alpha} treatment.

Authors:  K Briot; P Garnero; A Le Henanff; M Dougados; C Roux
Journal:  Ann Rheum Dis       Date:  2005-01-07       Impact factor: 19.103

6.  Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats.

Authors:  R B Kimble; J L Vannice; D C Bloedow; R C Thompson; W Hopfer; V T Kung; C Brownfield; R Pacifici
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

7.  Early hormonal changes affect the catabolic response to trauma.

Authors:  P Q Bessey; K A Lowe
Journal:  Ann Surg       Date:  1993-10       Impact factor: 12.969

8.  Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle.

Authors:  G Tiao; J M Fagan; N Samuels; J H James; K Hudson; M Lieberman; J E Fischer; P O Hasselgren
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

9.  Mucosal production of complement C3 and serum amyloid A is differentially regulated in different parts of the gastrointestinal tract during endotoxemia in mice.

Authors:  Q Wang; J J Wang; J E Fischer; P O Hasselgren
Journal:  J Gastrointest Surg       Date:  1998 Nov-Dec       Impact factor: 3.267

Review 10.  Bench-to-bedside review: ventilatory abnormalities in sepsis.

Authors:  Sheldon Magder
Journal:  Crit Care       Date:  2009-01-15       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.